NCT06265688 2026-03-25
First In Human Study of CX-2051 in Advanced Solid Tumors
CytomX Therapeutics
Phase 1 Recruiting
CytomX Therapeutics
CytomX Therapeutics
University of Oklahoma
Kumquat Biosciences Inc.
National University Hospital, Singapore
Second Affiliated Hospital of Guangzhou Medical University
Second Affiliated Hospital of Guangzhou Medical University
Second Affiliated Hospital of Guangzhou Medical University
Chengdu Baiyu Pharmaceutical Co., Ltd.
Telix Pharmaceuticals (Innovations) Pty Limited
TYK Medicines, Inc
Shijiazhuang Yiling Pharmaceutical Co. Ltd